NPI: 1770001877 · POWDERLY, KY 42367 · Professional Counselor · NPI assigned 09/08/2017
Authorized official RANALLO, RUSSELL controls 20+ related entities in our dataset. Read more
| Authorized Official | RANALLO, RUSSELL (SECRETARY) |
| Parent Organization | OWENSBORO HEALTH, INC |
| NPI Enumeration Date | 09/08/2017 |
Other providers sharing the same authorized official: RANALLO, RUSSELL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,051 | $254K |
| 2019 | 10,263 | $283K |
| 2020 | 6,767 | $172K |
| 2021 | 11,345 | $270K |
| 2022 | 16,632 | $426K |
| 2023 | 24,173 | $784K |
| 2024 | 24,767 | $874K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35,917 | 32,910 | $1.02M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,274 | 8,756 | $417K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,771 | 2,706 | $287K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,573 | 3,320 | $269K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6,483 | 6,221 | $190K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,597 | 5,223 | $140K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,862 | 1,813 | $114K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,648 | 1,548 | $89K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,852 | 4,397 | $64K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 585 | 575 | $62K |
| 71046 | Radiologic examination, chest; 2 views | 5,024 | 4,683 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,446 | 1,414 | $51K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 483 | 466 | $44K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,380 | 3,112 | $43K |
| 87634 | 546 | 539 | $32K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,184 | 1,159 | $18K |
| 87807 | 1,401 | 1,310 | $16K | |
| 74018 | 1,269 | 1,230 | $15K | |
| 36415 | Collection of venous blood by venipuncture | 2,784 | 2,595 | $14K |
| 20610 | 371 | 348 | $14K | |
| 73630 | 979 | 891 | $12K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 375 | 368 | $8K |
| 73610 | 591 | 531 | $7K | |
| 73030 | 562 | 526 | $7K | |
| 73564 | 427 | 412 | $6K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 99 | 95 | $6K |
| 71271 | 107 | 101 | $6K | |
| 73110 | 468 | 406 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 553 | 500 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 25 | 25 | $5K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 680 | 659 | $4K |
| 73130 | 307 | 280 | $4K | |
| 72110 | 181 | 170 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 103 | 97 | $3K |
| 90461 | 92 | 92 | $3K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 46 | 46 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 45 | 45 | $3K |
| 99243 | 32 | 30 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 67 | 65 | $2K |
| 73562 | 145 | 137 | $2K | |
| 72100 | 100 | 98 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 270 | 193 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 61 | 57 | $1K |
| 77080 | 24 | 24 | $1K | |
| 81003 | 2,597 | 2,439 | $989.37 | |
| 96127 | 347 | 336 | $967.80 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,047 | 975 | $962.34 |
| 90686 | 45 | 45 | $632.03 | |
| 73502 | 38 | 38 | $564.04 | |
| 76642 | 20 | 12 | $467.37 | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 18 | 14 | $452.23 |
| 76536 | 14 | 14 | $398.99 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 295 | 280 | $393.70 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 37 | 37 | $284.92 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 25 | 25 | $213.19 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 18 | 16 | $204.02 |
| 81025 | 37 | 29 | $164.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 62 | 52 | $138.64 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 38 | 28 | $128.62 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 13 | 13 | $123.01 |
| 87210 | 25 | 25 | $111.78 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 124 | 117 | $40.02 |
| 90670 | 15 | 15 | $36.80 | |
| 90698 | 12 | 12 | $36.80 | |
| 82962 | 13 | 12 | $23.12 | |
| 90633 | 43 | 43 | $18.40 | |
| 90710 | 12 | 12 | $0.00 | |
| 99024 | 1,314 | 1,052 | $0.00 |